Published in Cell Immunol on February 01, 1972
Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression. Infect Immun (1976) 1.35
Suppression of adjuvant disease by bacterial extracellular products. Ann Rheum Dis (1972) 0.78
Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats. Infect Immun (1979) 0.75
Cell surface immunoglobulin. XI. The appearance of an IgD-like molecule on murine lymphoid cells during ontogeny. J Exp Med (1975) 3.26
Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07
Effect of prostaglandin E 1 on adjuvant arthritis. Nature (1971) 2.02
Mechanisms underlying binding of immune complexes to macrophages. J Exp Med (1971) 2.00
Characteristics of mesenteric lymph node cells homing to gut-associated lymphoid tissue in syngeneic mice. J Immunol (1975) 1.84
Studies on the lymphocyte 5'-nucleotidase in chronic lymphocytic leukemia, infectious mononucleosis, normal subpopulations, and phytohemagglutinin-stimulated cells. Cancer Res (1974) 1.74
Origin of IgA-secreting plasma cells in the mammary gland. J Exp Med (1977) 1.71
Cell surface immunoglobulin. X. Identification of an IgD-like molecule on the surface of murine splenocytes. J Exp Med (1974) 1.70
Mesenteric lymph node B lymphoblasts which home to the small intestine are precommitted to IgA synthesis. J Exp Med (1977) 1.63
[Pharmacological susceptibility of cellular immunity]. Z Naturwiss Med Grundlagenforsch (1965) 1.53
Immunoglobulin-bearing and complement-receptor lymphocytes constitute the same population in human peripheral blood. J Clin Invest (1976) 1.46
Dissociation of hemolytic and lymphocyte-transforming activities of streptolysin S preparations. J Exp Med (1969) 1.45
Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease. Cell Immunol (1972) 1.42
H-2-linked genetic control of immune responsiveness to ovalbumin and ovomucoid. J Exp Med (1971) 1.40
Hormonal induction of the secretory immune system in the mammary gland. Proc Natl Acad Sci U S A (1978) 1.29
Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations. J Clin Invest (1976) 1.25
Ultrastructural, immunologic, and functional studies on Sézary cells: a neoplastic variant of thymus-derived (T) lymphocytes. Proc Natl Acad Sci U S A (1974) 1.24
Impairment of cell-mediated immune responses by Pseudomonas aeruginosa. Clin Exp Immunol (1971) 1.24
Antidotes to experimental -amanitin poisoning. Nat New Biol (1972) 1.24
Surface and intracellular markers of mouse mesenteric and peripheral lymph node and Peyer's patch cells. J Immunol (1974) 1.23
[Clinical death-cap (Amanita phalloides) poisoning: prognostic factors and therapeutic measures. Analysis of 205 cases]. Schweiz Med Wochenschr (1982) 1.20
Antagonistic effects to phalloidin, alpha-amanitin and extracts of Amanita phalloides. Agents Actions (1971) 1.16
Prostaglandin E 1 as a regulator of lymphocyte function. Selective action on B lymphocytes and synergy with procarbazine in depression of immune responses. Cell Immunol (1973) 1.15
Studies on the mechanism of binding of immune complexes to phagocytes. Nature (1969) 1.12
Accelerated rejection of skin homografts by vitamin A acid. Transplantation (1972) 1.04
Cell surface immunoglobulin. XIV. Synthesis, surface expression, and secretion of immunoglobulin by Peyer's patch cells in the mouse. J Immunol (1975) 0.99
Facilitation of tumour growth by Bacillus pertussis. Nature (1967) 0.99
[Protective action of hepatotoxic substances against lethal doses of a toxin from Amanita phalloides (phalloidin)]. Biochem Pharmacol (1966) 0.98
Migration and regulation of B-cells in the mucosal immune system. Ann N Y Acad Sci (1983) 0.97
Long bone erosions and ascites in progressive systemic sclerosis (scleroderma). J Rheumatol (1982) 0.96
Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol (1974) 0.95
Suppression of adjuvant arthritis by a new cytotoxic compound, rubidomycin. Ann Rheum Dis (1969) 0.95
A study of combined treatment with chemical immunosuppressants and antilymphocytic serum to prolong skin allograft survival. Transplantation (1969) 0.93
Functional and immunological characterization of the stimulation of human lymphocytes with a mitogen from group A streptococci (SM). Cell Immunol (1982) 0.92
High lymphocyte transformation with non-haemolytic streptococcal product. Nature (1968) 0.91
Lymphocyte transformation with streptolysin S preparations and inhibition of streptolysin S by serum in rheumatic fever and other rheumatic diseases. J Lab Clin Med (1972) 0.90
Poly I-poly C and endotoxins share immunosuppressive properties and increase the toxicity of alpha-amanitin and hexobarbital. Agents Actions (1971) 0.88
Treatment of Moloney lymphoma with lethal doses of dimethyl-myleran combined with injections of haemopoietic cells. Lancet (1969) 0.88
A comparative study of the effects of anti-tumour and immunosuppressive drugs on antibody-forming and erythropoietic cells. Clin Exp Immunol (1970) 0.87
Induction of Ia-like antigens by a group A streptococcal product with mitogenic activity. Transplant Proc (1981) 0.87
Antiarthritic and immunosuppressive effects of Pseudomonas aeruginosa. Agents Actions (1972) 0.87
Bone-marrow transplantation after antilymphocytic serum and lethal chemotherapy. Nature (1969) 0.87
Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran. Biomedicine (1974) 0.86
Lymphocyte 5'-nucleotidase: absence of detectable protein in chronic lymphocytic leukemia. Blood (1977) 0.86
Differentiation pathway of Peyer's patch precursors of IgA plasma cells in the secretory immune system. Cell Immunol (1981) 0.85
Drug-induced tolerance for skin allografts across the H-2 barrier in adult mice. Science (1967) 0.85
Suppression of cellular immunity by gram-negative bacteria. Antibiot Chemother (1969) 0.85
Development of the IgA system in the mammary gland. Adv Exp Med Biol (1978) 0.85
[Tolerance of large doses of oral zinc sulfate]. Schweiz Med Wochenschr (1981) 0.85
Rifampicin and cysteamine protect against the mushroom toxin phalloidin. Experientia (1974) 0.84
[Alteration of the tuberculin reaction by microbial polysaccharide]. Helv Physiol Pharmacol Acta (1967) 0.83
Effect of methylhydrazine derivatives on the survival of second-set skin homografts. Nature (1966) 0.83
T-cell help for the IgA response: the function of T cells from different lymphoid organs in regulating the proportions of plasma cells expressing various isotypes. Cell Immunol (1984) 0.83
Inhibition of rat adjuvant arthritis by a new immunosuppressive agent rubidomycin. Experientia (1968) 0.82
Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol (1990) 0.82
Cellular events in tolerance. I. Induction and loss of tolerance in neonatal and adult rats. Cell Immunol (1972) 0.81
Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes. Cancer Res (1976) 0.81
[Treatment of brittle fingernails with biotin]. Z Hautkr (1989) 0.81
Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol (1978) 0.80
Curative potencies against -amanitin poisoning by cytochrome c. Science (1972) 0.80
Induction of unresponsiveness to skin and heart allografts in mice by a synergistic treatment with procarbazine, antilymphocyte serum, and donor-type cells. Transplantation (1973) 0.80
Protection against ionising radiation and synergism with thiols by zinc aspartate. Br J Radiol (1986) 0.80
Con A-propagated, auto-reactive T cell clones that secrete factors promoting high IgA responses. Int Arch Allergy Appl Immunol (1988) 0.79
Hybrid resistance to BALB/c plasmacytomas. II. Radiation sensitivity and silica insensitivity of resistance to MPC-11. J Immunol (1979) 0.79
Thymus dependency of neonatal tolerance induction in the absence of detectable suppressor cells. Cell Immunol (1980) 0.79
[Immunosuppression as a concomitant effect]. Schweiz Med Wochenschr (1978) 0.79
Prolongation of canine renal allografts: plasma or liver instead of blood transfusions combined with preoperative nonspecific immunosuppression. Transplant Proc (1979) 0.79
Treatment of human amatoxin mushroom poisoning. Myths and advances in therapy. Med Toxicol (1987) 0.78
Suppression of adjuvant disease by bacterial extracellular products. Ann Rheum Dis (1972) 0.78
The role of the thymus during the induction of tolerance of a thymus-dependent antigen. J Immunol (1973) 0.78
Xenografts in pharmacologically immunosuppressed mice as a model to test the chemotherapeutic sensitivity of human tumors. Int J Cancer (1986) 0.78
Adenosine and adenosine analogues are more toxic to chronic lymphocytic leukemia than to normal lymphocytes. Blood (1983) 0.77
Protection against acute ethanol toxicity in mice by zinc aspartate, glycols, levulose and pyritinol. Agents Actions (1985) 0.77
A novel IgA receptor expressed on a murine B cell lymphoma. J Immunol (1992) 0.77
Keyhole limpet hemocyanin-propagated Peyer's patch T cell clones that help IgA responses. J Immunol (1988) 0.77
Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2. J Immunol (1979) 0.77
Protection by bone marrow grafts against lethal doses of 5-fluorouracil. Eur J Cancer Clin Oncol (1984) 0.76
Synergism of organic zinc salts and sulfhydryl compounds (thiols) in the protection of mice against acute ethanol toxicity, and protective effects of various metal salts. Agents Actions (1987) 0.76
Synergistic toxicity of endotoxins with oxytetracycline and tetracycline. Lancet (1972) 0.76
In vivo and in vitro immunomodulatory ability of streptococcal mitogen: effects on adjuvant disease in the rat; on homograft rejection in the mouse; and on the appearance of Ia antigens on human T lymphocytes. Drugs Exp Clin Res (1985) 0.76
Growth of human tumors in mice after short-term immunosuppression with procarbazine, cyclophosphamide, and antilymphocyte serum. Transplantation (1980) 0.76
Antagonistic effects against single lethal doses of Amanita phalloides. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.76
Characterization of the binding of 125I-labelled succinylated porcine relaxin to human and mouse fibroblasts. J Reprod Fertil (1980) 0.76
In vivo and in vitro antiinflammatory and immunoregulating properties of streptococcal mitogen: effects on adjuvant disease in the rat, on homograft rejection in the mouse, and on the appearance of Ia antigens on human T lymphocytes. Agents Actions (1986) 0.75
Effect of thoracic duct drainage on the primary and secondary immune responses in rats. Induction of immunological tolerance. Immunology (1972) 0.75
Influence of ethanol on toxicity of paraquat and Amanita phalloides. Lancet (1992) 0.75
A pilot study using a staph protein A column (Prosorba) to treat refractory rheumatoid arthritis. J Rheumatol (1999) 0.75
Genetic control of resistance to tumors. Am J Pathol (1978) 0.75
Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats. Infect Immun (1979) 0.75
Shortened survival of skin allografts in mice after treatment with pus lyophilizates. Clin Exp Immunol (1973) 0.75
Attempted prevention of arteriolar lesions in accelerated rat hypertension by immunosuppression. Br J Exp Pathol (1970) 0.75
Further studies pertaining to a B. pertussis factor inhibiting the tuberculin reaction. Experientia (1966) 0.75
Another chance for thalidomide. Lancet (1966) 0.75
[Injurious effects in death-cups]. Praxis (1966) 0.75
A new IgA receptor expressed on a highly activated murine B cell lymphoma. Adv Exp Med Biol (1995) 0.75
[Uptake of vital H3-labeled deoxyribonucleic acid in spleen and bone marrow cells in vitro]. Nucl Med (Stuttg) (1963) 0.75